An evaluation suggested there was no overall net clinical benefit in patients receiving the drug in the study , the companies said in the statement distributed by Business Wire .
An evaluation of 240 arthritis patients suggested there was no overall net clinical benefit from taking the medicine , the companies said in the statement distributed by Business Wire .